This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Don't Give Up on Gilead Following a Weak Q1

After reporting a disappointing first quarter on Friday, the biopharma company could regain some value amid court developments over its patent lawsuit with Merck.

Obamacare vs. the FTC: When It Comes to Hospital Mergers, Uncle Sam Is Confused

Obamacare has hospitals and other health care entities scrambling to get bigger, but the FTC is having more success fighting mergers than ever. What gives?

Jim Cramer: Investors Should Flock to Pharma

Cramer remains bullish on drug makers including Johnson & Johnson, Bristol-Myers and Allergan.

Cardinal Health Sinks After Trimming Full-Year Guidance

Never mind the Ohio health care services company's better-than-anticipated Q3 earnings.

Thermo Fisher Demonstrates Impressive Quarter

The maker of scientific instruments hiked full-year expectations in light of its $1.3 billion deal for Affymetrix.

How Anthem Is Handling Its Obamacare Burden Better Than UnitedHealth

The health insurance giant doesn't plan to add to or exit any of its 14 Obamacare exchanges, though that could change if its $54.2 billion acquisition of Cigna is completed.

Investors Likely to Cheer Sale of Verisk's Health Unit

Analysts are optimistic Verisk's $820 million sale of Verisk Health will provide a long-term boost to the data and risk analytics company's stock.

Is Now the Time to Jump on Allergan?
Is Now the Time to Jump on Allergan?

04/25/16 - 01:31 PM EDT

Pfizer and Allergan scrapped their $160 billion deal to combine earlier this month following a tax clampdown by the Treasury Department.

Questions Mount at Valeant, Perrigo Amid Executive Shuffle

Joseph Papa has left Perrigo to head up Valeant as its new chief executive.

Jim Cramer -- Under Armour Is a Long-Term Play

Under Armour, the athletic-wear maker represented by NBA superstar Stephen Curry, will post earnings Thursday morning before the opening bell.

Page 1 of 18
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs